Literature DB >> 24863154

Reduction of acute hospital admissions and improvement in outpatient attendance by intensified renal palliative care clinic follow-up: the Hong Kong experience.

Kwok Ying Chan1, Hon Wai Benjamin Cheng2, Desmond Y H Yap3, Terence Yip4, Cho Wing Li2, Mau Kwong Sham2, Yim Chi Wong2, Wai Kee Vikki Lau2.   

Abstract

BACKGROUND: End-stage renal failure patients often fail to attend scheduled renal palliative care clinic (RPCC) follow-up because of acute hospital admissions, causing negative impact on patients' well-being and health care burden. MEASURES: The rates of RPCC attendance, emergency department (ED) attendance, and acute hospital admission per patient from January 2013 to June 2013 were analyzed. INTERVENTION: Patients who had more than one ED visit within three months were invited to intensify their RPCC follow-up schedule for symptom assessment, medical advice, psychosocial-spiritual care, and social worker support in the subsequent three months. OUTCOMES: Nineteen patients were included. The rate of ED attendance (2.63 vs. 0.63, P < 0.007) and acute hospital admission (1.59 vs. 0.58, P < 0.009) was reduced significantly after intensified follow-up. Clinic attendance rates improved from 56% to 85%. CONCLUSIONS/LESSONS LEARNED: Our pilot results suggested that intensifying RPCC follow-up minimized the utilization of acute medical services and improved outpatient attendance at RPCC.
Copyright © 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Renal palliative care; clinic; emergency department visit; hospitalization; palliative care follow-up; quality improvement

Mesh:

Year:  2014        PMID: 24863154     DOI: 10.1016/j.jpainsymman.2014.04.010

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

Review 1.  Multicomponent Palliative Care Interventions in Advanced Chronic Diseases: A Systematic Review.

Authors:  Veerawat Phongtankuel; Lauren Meador; Ronald D Adelman; Jordan Roberts; Charles R Henderson; Sonal S Mehta; Tessa Del Carmen; M C Reid
Journal:  Am J Hosp Palliat Care       Date:  2016-11-10       Impact factor: 2.500

2.  Palliative care for a mentally incompetent end stage renal failure patient: why is it important?

Authors:  Kwok-Ying Chan; Terence Yip; Mau-Kwong Sham; Benjamin Hon-Wai Cheng; Cho-Wing Li; Yim-Chi Wong; Vikki Wai-Kee Lau
Journal:  Case Rep Nephrol       Date:  2015-03-09

3.  The impact of community-based palliative care on acute hospital use in the last year of life is modified by time to death, age and underlying cause of death. A population-based retrospective cohort study.

Authors:  Katrina Spilsbury; Lorna Rosenwax; Glenn Arendts; James B Semmens
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

4.  Impact of Applying Palliative Care on Symptoms and Survival of Patients with Advanced Chronic Disease Admitted to the Emergency Department.

Authors:  Jose P Amado; Rolando Vasquez; Roberto Huari; Liliana Rimache; Rosa Lizonde
Journal:  Indian J Palliat Care       Date:  2020-08-29

5.  Emergency Department Utilization Among Maintenance Hemodialysis Patients: A Systematic Review.

Authors:  Gregory Han; Andrew Bohmart; Heba Shaaban; Keith Mages; Caroline Jedlicka; Yiye Zhang; Peter Steel
Journal:  Kidney Med       Date:  2021-12-03

6.  Rapid Electronic Capturing of Patient-Reported Outcome Measures in Older Adults With End-Stage Renal Disease: A Feasibility Study.

Authors:  Jennifer Gabbard; Christopher J McLouth; Gretchen Brenes; Sophie Claudel; Samantha Ongchuan; John Burkart; Nicholas Pajewski; Kathryn E Callahan; Jeff D Williamson; Mariana Murea
Journal:  Am J Hosp Palliat Care       Date:  2020-09-16       Impact factor: 2.090

7.  Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life.

Authors:  Katrina Spilsbury; Lorna Rosenwax
Journal:  BMC Palliat Care       Date:  2017-12-08       Impact factor: 3.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.